Takano, K., Bando, S., Miyatsuka, T., Shichiri, M., Taguchi, T., Motomiya, T., . . . Taguchi, M. (2022). Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes. Endocrine Journal, 69(6), 681-687. https://doi.org/10.1507/endocrj.EJ21-0696
Chicago Style (17th ed.) CitationTakano, Koji, Satoru Bando, Takeshi Miyatsuka, Masayoshi Shichiri, Tomomi Taguchi, Tetsuya Motomiya, Raishi Ichikawa, Kazumi Fujimoto, and Madoka Taguchi. "Effects of Luseogliflozin on the Secretion of Islet Hormones and Incretins in Patients with Type 2 Diabetes." Endocrine Journal 69, no. 6 (2022): 681-687. https://doi.org/10.1507/endocrj.EJ21-0696.
MLA (9th ed.) CitationTakano, Koji, et al. "Effects of Luseogliflozin on the Secretion of Islet Hormones and Incretins in Patients with Type 2 Diabetes." Endocrine Journal, vol. 69, no. 6, 2022, pp. 681-687, https://doi.org/10.1507/endocrj.EJ21-0696.